CINECA IRIS Institutional Research Information System

VALDISERRA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.471
AS - Asia 1.416
EU - Europa 1.124
SA - Sud America 199
AF - Africa 99
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.416
SG - Singapore 490
IT - Italia 368
CN - Cina 308
SE - Svezia 179
HK - Hong Kong 170
BR - Brasile 156
IN - India 116
DE - Germania 115
VN - Vietnam 111
GB - Regno Unito 103
FI - Finlandia 82
FR - Francia 70
JP - Giappone 63
NL - Olanda 44
CI - Costa d'Avorio 38
BG - Bulgaria 33
TR - Turchia 27
CA - Canada 26
KR - Corea 26
PL - Polonia 20
RU - Federazione Russa 20
AU - Australia 19
AT - Austria 17
MX - Messico 16
BD - Bangladesh 15
SN - Senegal 15
AR - Argentina 13
ID - Indonesia 13
IQ - Iraq 11
NG - Nigeria 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
ES - Italia 9
IR - Iran 9
LT - Lituania 9
MA - Marocco 9
PT - Portogallo 9
SA - Arabia Saudita 9
UZ - Uzbekistan 8
PK - Pakistan 7
VE - Venezuela 7
EC - Ecuador 6
PE - Perù 6
UA - Ucraina 6
EG - Egitto 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CH - Svizzera 4
CL - Cile 4
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
AL - Albania 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
Totale 5.333
Salva come PNG Salva come JPEG
Città #
Ashburn 298
Singapore 284
San Jose 202
Dallas 183
Hong Kong 166
Santa Clara 160
Shanghai 94
Los Angeles 68
Munich 62
Boardman 60
Chandler 55
Florence 51
Beijing 46
New York 42
London 41
Tokyo 41
Pisa 40
Abidjan 38
Turku 38
Helsinki 35
Sofia 33
Ho Chi Minh City 29
Hanoi 27
Serra 27
Council Bluffs 26
Mumbai 26
Kent 21
Lauterbourg 21
Frankfurt am Main 19
Hyderabad 19
Massa 19
Princeton 19
Rome 19
Fairfield 18
Istanbul 18
Hefei 16
Milan 16
Dakar 15
Lawrence 15
Denver 14
Buffalo 13
Warsaw 13
Atlanta 12
Chicago 12
Medford 12
Brooklyn 11
Da Nang 11
Houston 11
Phoenix 11
San Francisco 11
Seoul 11
Lagos 10
São Paulo 10
Wilmington 10
Amsterdam 9
Ogden 9
Redondo Beach 9
Washington 9
Bengaluru 8
Fuzhou 8
Jakarta 8
Orem 8
Sassuolo 8
Tashkent 8
Baltimore 7
Chennai 7
Johannesburg 7
Livorno 7
Naples 7
Redwood City 7
Vienna 7
Jeju City 6
Lappeenranta 6
Mexico City 6
Poplar 6
Roubaix 6
Turin 6
Vancouver 6
Belgrade 5
Belo Horizonte 5
Buenos Aires 5
Cambridge 5
Detroit 5
Düsseldorf 5
Haiphong 5
Manchester 5
Marseille 5
Miami 5
New Malden 5
Nuremberg 5
Paris 5
Philadelphia 5
Prague 5
Pristina 5
Quanzhou 5
Rio de Janeiro 5
Riyadh 5
The Bronx 5
Toronto 5
Torres Vedras 5
Totale 2.864
Salva come PNG Salva come JPEG
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 839
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 198
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 178
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 176
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 175
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 174
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 160
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 155
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 150
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 148
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 145
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 142
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 138
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 136
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 135
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 133
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 132
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 130
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 128
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 128
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 128
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 122
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 121
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 112
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 111
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 111
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 109
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 96
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 95
Communicating Drug Safety 89
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 86
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 80
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 79
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 77
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 74
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 65
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 59
Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling 36
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging 23
Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study 16
The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives 13
Totale 5.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 4 2 54 60 55 24 15 12 15 9 22 56
2022/2023373 59 81 30 17 21 24 22 5 77 0 37 0
2023/2024407 3 11 23 3 30 46 58 36 32 26 67 72
2024/20251.574 34 64 85 132 99 159 159 58 160 171 186 267
2025/20262.580 163 137 216 189 208 105 300 69 170 189 743 91
2026/2027112 112 0 0 0 0 0 0 0 0 0 0 0
Totale 5.402